Where I see patients (2)
My reviews
Selected research
-
HER2 overexpression in urothelial carcinoma with GATA3 and PPARG copy number gains.
The oncologist
-
NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024.
Journal of the National Comprehensive Cancer Network : JNCCN
-
Immune Modulation with RANKL Blockade through Denosumab Treatment in Patients with Cancer.
Cancer immunology research
5.0